SCHEMBL2627550

SCHEMBL2627550

Cc1ccc(-c2cc(-c3ccc(C(F)(F)F)cc3)cc(-c3ccc4c(c3)c3c5ccccc5c5ccc6ccccc6c5c3n4-c3ccccc3)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 2/20 0.37
▸ MAT2A P31153 1/20 0.35
▸ GAA P10253 2/20 0.35
▸ MGAM O43451 1/20 0.35
▸ SI P14410 1/20 0.35
▸ MGAM2 Q2M2H8 1/20 0.35
▸ ALDH1A1 P00352 5/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ ERBB2 P04626 2/20 0.34
▸ EGFR P00533 1/20 0.34
▸ KIF11 P52732 2/20 0.33
▸ MAPT P10636 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ TDP2 O95551 1/20 0.32
▸ TRPV1 Q8NER1 1/20 0.32
▸ ICMT O60725 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ PPARD Q03181 1/20 0.32
▸ DHODH Q02127 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10063544 0.95 KIF11 (0.36) PIK3CAMAT2AGAAMGAMSI
SCHEMBL2627518 0.83 ALDH1A1 (0.36) PIK3CAMAT2AGAAMGAMSI
SCHEMBL2627556 0.82 MAPT (0.39) PIK3CAALDH1A1MAPTPIK3CDMTOR
SCHEMBL22155592 0.79 MAT2A (0.38) PIK3CAMAT2AGAAMGAMSI
SCHEMBL16482679 0.78 KDM4E (0.41) GAAALDH1A1RXFP1ERBB2EGFR
SCHEMBL2633100 0.77 KIF11 (0.39) MAT2AGAAMGAMSIMGAM2
SCHEMBL20311923 0.76 L3MBTL1 (0.36) ALDH1A1MAPTMAPK1
SCHEMBL2627555 0.76 JAK2 (0.32) PIK3CA
SCHEMBL2627559 0.76 JAK2 (0.34) MAT2AERBB2EGFR
SCHEMBL2627489 0.76 ESR1 (0.44) GAAALDH1A1MAPTMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9362506-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-07 — — US disclosed
US-20140291654-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2014-10-02 — — US disclosed
US-8815417-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2014-08-26 — — US disclosed
US-20120097929-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2012-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120097929-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY2, CRY1, CCNE2 PIK3CA 4521/4885MAT2A 2654/4885GAA 3072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback